An 81-year-old patient’s journey through cancer care raises a provocative question: Why is healthcare investing in AI to manage administrative failures instead of preventing them upstream? “The next challenge for clinical AI is not only better task performance, but better operational follow-through across the care journey.” -Saif Khairat and Charles Safran, in a peer-reviewed perspective published in npj Health Systems on August 5, 2026.

Imagine taking a drug to cure a lung disease only to wake up feeling six years younger. 🧬 It sounds like science fiction, but it’s the new reality of AI in drug discovery. In this episode, we dive into the fascinating story of Rentosertib, the accidental anti-aging breakthrough that is forcing the medical world to rethink everything. We bridge the gap between Silicon Valley venture capital and cutting-edge longevity science to explain how companies are using a clever 'disease-first' strategy to bypass regulatory hurdles and fast-track the future of human health. What You Will Discover: - The Rentosertib Paradox: How a lung medication became the world’s most talked-about anti-aging candidate. 🧪 - The Disease-First Strategy: Why investors are betting big on longevity masquerading as disease treatment. - Beyond Hype: The real bottlenecks, clinical trial realities, and the truth about AI-designed pharmaceuticals. - The Future of You: How genetic editing and AI are turning biology into a 'software problem' that can be solved. Whether you're a biohacker looking for the next protocol, an investor hunting for alpha, or just a skeptic wondering if we'll ever reach age 150, this conversation is for you. 🚀 Ready to live longer? Hit that subscribe button and join the future of human evolution!  

With the Center for Organoid Systems (COS), TUM has opened a new biotechnology research center dedicated to organoids, lab-grown miniature organ-like structures

Optimismo que nos une

YouTube video by TUMuenchen

Erleben Sie in fünf Lebensstationen, wie KI Diagnosen präziser, Therapien individueller und die Medizin von morgen menschlicher macht.